- Home
- SAVA vs SRFM Comparison
SAVA vs SRFM Comparison
Compare SAVA & SRFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SAVA
- SRFM
- Stock Information
- Founded
- SAVA 1998
- SRFM 2011
- Country
- SAVA United States
- SRFM United States
- Employees
- SAVA N/A
- SRFM N/A
- Industry
- SAVA Biotechnology: Pharmaceutical Preparations
- SRFM Transportation Services
- Sector
- SAVA Health Care
- SRFM Consumer Discretionary
- Exchange
- SAVA Nasdaq
- SRFM Nasdaq
- Market Cap
- SAVA 157.5M
- SRFM 153.7M
- IPO Year
- SAVA N/A
- SRFM 2023
- Fundamental
- Price
- SAVA $2.82
- SRFM $2.40
- Analyst Decision
- SAVA Buy
- SRFM Buy
- Analyst Count
- SAVA 2
- SRFM 4
- Target Price
- SAVA $5.00
- SRFM $5.81
- AVG Volume (30 Days)
- SAVA 1.2M
- SRFM 2.5M
- Earning Date
- SAVA 11-12-2025
- SRFM 11-12-2025
- Dividend Yield
- SAVA N/A
- SRFM N/A
- EPS Growth
- SAVA N/A
- SRFM N/A
- EPS
- SAVA N/A
- SRFM N/A
- Revenue
- SAVA N/A
- SRFM $108,158,000.00
- Revenue This Year
- SAVA N/A
- SRFM N/A
- Revenue Next Year
- SAVA N/A
- SRFM $18.06
- P/E Ratio
- SAVA N/A
- SRFM N/A
- Revenue Growth
- SAVA N/A
- SRFM N/A
- 52 Week Low
- SAVA $1.15
- SRFM $1.63
- 52 Week High
- SAVA $33.98
- SRFM $9.91
- Technical
- Relative Strength Index (RSI)
- SAVA 38.79
- SRFM 22.11
- Support Level
- SAVA $2.65
- SRFM $3.04
- Resistance Level
- SAVA $3.30
- SRFM $3.73
- Average True Range (ATR)
- SAVA 0.21
- SRFM 0.27
- MACD
- SAVA -0.07
- SRFM -0.11
- Stochastic Oscillator
- SAVA 18.02
- SRFM 1.16
About SAVA Cassava Sciences Inc.
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia. It has one business segment: the development of novel drugs and diagnostics.
About SRFM Surf Air Mobility Inc.
Surf Air Mobility Inc provides a regional air mobility platform to connect communities sustainably. The company is an electric aviation and air travel company expanding the category of regional air travel and reinventing flying through electrification. The company is building a regional air mobility ecosystem to sustainably connect the world's communities. It generates revenue through air mobility services.